Literature DB >> 9467797

Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence.

J Grabowski1, G Arnoni, R Elk, H Rhoades, J Schmitz.   

Abstract

To summarize, perhaps most important, but most difficult to achieve will be commonalties and standardization across trials so that rigorous comparison is possible. Researchers will do well to examine clinical trials in other areas, mimicking those elements that are compatible, avoiding those that are not, and above all, avoiding costly reinvention.

Mesh:

Year:  1997        PMID: 9467797

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  4 in total

Review 1.  Illusory predictors: Generalizability of findings in cocaine treatment retention research.

Authors:  Angela L Stotts; Marc E Mooney; Shelly L Sayre; Meredith Novy; Joy M Schmitz; John Grabowski
Journal:  Addict Behav       Date:  2007-05-03       Impact factor: 3.913

2.  Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression.

Authors:  Adam M Leventhal; Marc E Mooney; Katherine A DeLaune; Joy M Schmitz
Journal:  Am J Addict       Date:  2006 Sep-Oct

3.  Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.

Authors:  Marc E Mooney; Joy M Schmitz; F Gerard Moeller; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2006-11-28       Impact factor: 4.492

4.  Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

Authors:  Joy M Schmitz; Marc E Mooney; F Gerard Moeller; Angela L Stotts; Charles Green; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2007-12-27       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.